None listed
Conditions
Interventions
Enhanced upSCALE digital immunization module
Standard immunization services
Sponsors
UNICEF
Malaria Consortium
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Parent/Guardian/Caregiver has a child aged 3-59 months in the selected districts. • Child has been resident in the selected district for at least one month prior to data collection • Parent/Guardian/Caregiver is willing and able to give informed consent for their child’s participation in the trial in the selected districts
Exclusion criteria
Exclusion criteria: • Children who have not resided in the selected district for at least one month prior to data collection • Those whose primary residence is outside the catchment areas of the selected health facilities in Mocuba or Nicoadala districts. • Those unable to provide informed consent due to language barriers, lack of comprehension, or other constraints (e.g., minors acting as caregivers without legal consent authority).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction in proportion of zero-dose children, defined as the proportion of children who have not received the first dose of the pentavalent vaccine (Penta1) in the study areas. For this study, we will consider children aged 3-59 months, assuming that at 3 months, a child should have received at least Penta1 as per the vaccination schedule. | — |
Secondary
| Measure | Time frame |
|---|---|
| The reduction in the proportion of under-immunised children 6-59 who have not received the third dose of pentavalent vaccine (Penta3) before and after the implementation will be assessed as a secondary effectiveness outcome. | — |
Countries
Mozambique
Contacts
Public ContactEsmeralda Karajeans
Immunization Specialist UNICEF
Outcome results
None listed